Adjuvant trastuzumab for breast cancer - The other side of the coin

被引：5

作者：

Gopalakrishnan, S ^{[1
]}

Linnane, J ^{[1
]}

机构：

[1] Walsall Teaching Primary Care Trust, Walsall WS1 1TE, W Midlands, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 331卷 / 7526期

关键词：

D O I：

10.1136/bmj.331.7526.1202-c

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1202 / 1203

页数：2

共 3 条

[1] Adjuvant trastuzumab for breast cancer - We need to ensure that equity exists for access to effective and expensive treatments [J].

Dent, R ;

Clemons, M .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7524) :1035-1036

[2]

*OFF NAT STAT, HLTH BREAST CANC

[3] Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer [J].

Piccart-Gebhart, MJ ;

Procter, M ;

Leyland-Jones, B ;

Goldhirsch, A ;

Untch, M ;

Smith, I ;

Gianni, L ;

Baselga, J ;

Bell, R ;

Jackisch, C ;

Cameron, D ;

Dowsett, M ;

Barrios, CH ;

Steger, G ;

Huang, CS ;

Andersson, M ;

Inbar, M ;

Lichinitser, M ;

Láng, I ;

Nitz, U ;

Iwata, H ;

Thomssen, C ;

Lohrisch, C ;

Suter, TM ;

Ruschoff, J ;

Süto, T ;

Greatorex, V ;

Ward, C ;

Straehle, C ;

McFadden, E ;

Dolci, MS ;

Gelber, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1659-1672

← 1 →